Pharma Focus Asia

Repligen

LATEST NEWSRead more...

25

Jul 2024

Eisai and EcoNaviSta Forge Business Partnership to Develop a Dementia Care Ecosystem and Initiate Collaboration

Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta

25

Jul 2024

Pfizer Reveals Successful Phase 3 Outcomes for Hemophilia A Gene Therapy Candidate

Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A

24

Jul 2024

BeiGene Launches U.S. Biologics Manufacturing and R&D Facility, Advancing Global Expansion to Serve More Patients

BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics

24

Jul 2024

Brenig Therapeutics Raises $65 Million in Series A Funding to Advance Pre-Clinical Pipeline for Parkinson’s Disease

Brenig Therapeutics Inc a trailblazer in neurologyfocused drug development utilizing an AIMLbased discovery platform has successfully completed a million Series A funding round The round was led by New

24

Jul 2024

Flagship Pioneering Introduces Abiologics: Revolutionizing Biotherapeutics with Advanced Capabilities

Flagship Pioneering has introduced Abiologics a new bioplatform company that aims to transform the field of biologics through the development of a novel class of medicines called Synteins

23

Jul 2024

MasterControl Introduces GxPAssist AI to Enhance Life Science Processes

MasterControl a leader in manufacturing and quality management software for regulated industries has introduced GxPAssist AI a suite of generative artificial intelligence AI tools designed to optimize processes for quality and manufacturing professionals These tools aim to enhance efficiency and ens...

Solovpe

press releasesRead more...

25

Jul 2024

Bio-Thera Solutions Announces Regulatory Filing Acceptance for BAT2206, a Proposed Biosimilar to Stelara® in the US and EU

BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed

25

Jul 2024

COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides

NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate

25

Jul 2024

Autobahn Therapeutics Completes Oversubscribed $100 Million Series C Financing to Advance Pipeline of Novel Therapeutics for Depression and Other CNS Disorders

Autobahn Therapeutics a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders today announced the closing of an oversubscribed

24

Jul 2024

Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics

Triastek Inc a global leader in D printing pharmaceuticals today announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE a next generation

24

Jul 2024

Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs

Waters Corporation announced today the global release of the TA Instruments Rapid ScreeningDifferential Scanning Calorimeter designed for biopharmaceutical developers

24

Jul 2024

IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis

IASO Biotechnology a biopharmaceutical company dedicated to discovering developing manufacturing and commercializing innovative cell therapy and antibody products announced that the investigational new drug application for the independently developed

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
Hexagon - Expert Insights Webinar
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    European Lead Factory

    Head of European Screening Centre

    Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature
  • Articles

    3-dimensional Bioprinting of Tissue and Organs From bench to bedside

    Since time immemorial wounds and tissue damage have inflicted enormous pain and cosmetic exasperation on humans However despite being a rather common phenomenon the human body is limited by its regenerative capabilities Varghese Shinde Additionally the conventional methods employed for the management of these are filled with lacunae perils

EDITORIAL SECTION